Page 153 - ESHRE2019

ACKNOWLEDGEMENTS
Slovenian Research Agency grants J3‐6799, J3‐8212, HMGU grant G‐508200‐016
REFERENCES
• Alhamdani M.S.S., Schroeder C. and Hohisel J.D. Oncoproteomic profiling with antibody microarrays, Genome Medicine, 2009, 1:68.
• Bouatra S., Aziat F., Mandal R. et al. The human urine metabolome. PLoS ONE, 2013, 8(9): e73076.
• Dorien F.O., Flores I., Waelkens E., D‘Hooghe T. Noninvasive diagnosis of endometriosis: Review of current peripheral blood and endometrial biomarkers. Best Practice & Res. Clin. Obstet. Gynecol. 2018,
50, 72‐83.
• Dutta M., Subramani E., Taunk K. et al. Investigation of serum proteome alterations in human
endometriosis. J. Proteomics, 2015, 182‐196.
• Fassbender A., Vodolazkaia A., Saunders P. et al. Biomarkers of endometriosis. Fertil. Steril. 2013, 99, 4,
1135‐1145.
• Geyer P.E., Holdt L.M., Teupser D., Mann M. Revisiting biomarker discovery by plasma proteomics. Mol.
System. Biol. 2017, 13, 942.
• Gupta D., Hull, M.L., Fraser I. et al. Endometrial biomarkers for the non‐invasive diagnosis of
endometriosis, Cochrane Database of Systematic Reviews, 2016, 4, CD012165.
• Jorgensen H., Hill A.S., Beste M.T. et al. Peritoneal fluid cytokines related to endometriosis in patients
evaluated for infertility. Fertil. Steril. 2017, 107, 5, 1191‐1199.
• Letsiou S., Peterse D.P. , Fassbender A. et al. Endometriosis is associated with aberrant metabolite
profiles in plasma. Fertil. Steril. 2017, 107, 699‐706.
42
41
148
PRECONGRESS COURSE 03 I VIENNA, AUSTRIA – 23 JUNE 2019 151